ment activation products [3][4][5]. One of these products, Background. Increases in plasma anaphylatoxins fre-anaphylatoxin C3a, is cleaved from the third componquently are used as an index of haemodialysis mem-ent of complement during its activation [6 ]. Another brane biocompatibility; however, their plasma levels anaphylatoxin, C5a, a fragment of the fifth component may be influenced by the loss of anaphylatoxins into of complement, is generated as a result of C5 activation the dialysate compartment.
Introduction
ins significantly changes their plasma levels. To this end, we have compared the generation and compartCurrent evidence suggests that biocompatibility char-mental distribution of C3a and C5a within a low flux acteristics and solute clearance of dialysis membranes dialyser with those in a high flux dialyser, both of influence the long-term clinical outcome of chronic which are made from the same material (polysulfone) haemodialysis patients [1, 2] . Complement activation by the same manufacturer. In addition, we compared occurs almost universally during clinical haemodialysis these polysulfone dialysers with two other types of with the consequential generation of several complemembranes that theoretically prohibit anaphylatoxin transport. One of these is CuprophanA membrane
Correspondence and offprint requests to: Alfred K. Cheung, MD, which, despite its high capacity to activate complement, 85 N. Medical Drive Front, University of Utah, Salt Lake City, UT 84112, USA.
contains small pores. The other is AN69A membrane,
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Anaphylatoxins and dialysis membranes 1177 lysis tubings (Gambro Medical Care). The dialysate was made from a co-polymer of acrylonitrile and methallyl recirculated in a closed circuit (to avoid net ultrafiltration) sulfonate, which is known to adsorb anaphylatoxins at a flow rate of 60 ml/min using the same model of pump [11] [12] [13] .
and tubings. Two control experiments were performed in which heparinized blood was recirculated through tubings alone at 200 ml/min using the same model of pump and
Subjects and methods
tubings in the absence of a dialyser and dialysate. There was no clotting or leaking of blood in the dialysis circuit for any Haemodialysers of the experiments. While the entire blood compartment was handled in a sterile manner and the dialysate was freshly The four different types of commercial hollow fibre mem-prepared for the experiments, the presence or absence of brane dialysers employed were (i) high flux polysulfone (F60, endotoxins was not tested specifically. Fresenius, Concord, CA); (ii) low flux polysulfone (F6, Fresenius); (iii) CuprophanA (2308, Travenol, Deerfield, IL); and (iv) AN69A (Filtral 12, Hospal, East Brunswick, NJ ) .
Blood samples
Some of the characteristics of these dialysers are listed in Table 1 . All four types of membranes have identical nominal Blood samples (0.9 ml each) were collected from the beaker surface areas. The two types of polysulfone membranes with after 0, 15, 30, 60, 90 and 120 min of recirculation in 0.1 ml different porosities were the primary focus of this study. of 0.2 M Na 2 EDTA. Plasma was separated immediately by centrifugation. Dialysate samples (0.9 ml ) were collected at Blood 0, 60 and 120 min in 0.1 ml of 0.2 M Na 2 EDTA. Plasma and dialysate samples were stored at −70°C until assay. Six healthy human volunteers donated blood for the dialyser studies. Each volunteer donated blood on four separate days for experiments on each of the four types of membranes
Assays for C3a and C5a
performed in random order. For each experiment, 200 ml of fresh blood was obtained by needle puncture of an antecubital C3a and C5a in the plasma and dialysate samples were vein of the volunteer. The blood was collected in porcine measured using radioimmunoassays (Amersham, Arlington unfractionated sodium heparin (Elkins-Sinn, Cherry Hill, Heights, IL). The C3a assay detects both the anaphylatoxin NJ ) at a final concentration of 2 U/ml under sterile condiand its desarginine derivative, C3a desArg . Similarly, the C5a tions, and used in experiments within 15 min.
assay detects both the anaphylatoxin and its desarginine derivative, C5a desArg . C3a and C3a desArg will be denoted by
Simulated haemodialysis circuit
C3a, while C5a and C5a desArg will be denoted by C5a hereafter. The ranges of detection for C3a and C5a were The in vitro haemodialysis circuit was assembled as shown 0.04-1 and 0.01-0.4 mg/ml, respectively. Samples were in Figure 1 . Prior to use, the blood compartment of the diluted with phosphate-buffered saline (PBS ) containing dialyser was rinsed with sterile normal saline, which sub-EDTA as necessary for the assays. sequently was removed with an air rinse. The heparinized blood (200 ml ) for the dialyser blood compartment was maintained at 37°C in a beaker which was partially immersed in a water bath. Commercial dialysate solution for the Statistical analyses dialysate compartment, containing 137 mEq/l Na+, 3.0 mEq/l K+, 3.0 mEq/l Ca2+, 0.75 mEq/l Mg2+, 107 mEq/l All concentrations of anaphylatoxins that were below the detection limit of the respective assays were considered to be Cl−, 4.0 mEq/l acetate, 33 mEq/l bicarbonate and 200 mg/dl dextrose, was freshly prepared using a Century 3 dialysis zero. All results are presented as mean±SE. Levels of anaphylatoxins at various time points were evaluated using machine (Gambro Medical Care, Lakewood, CO). The volume of dialysate used varied depending on the dialyser analysis of variance with repeated measures in order to determine if changes in the levels occurred during the recircumodel; it was 280 ml for the F60 and F6 dialysers and 200 ml for the CuprophanA and AN69A dialysers. Blood was recir-lation. Differences between two membranes at any given time point were compared using a non-parametric paired sign culated through the blood compartment of the dialyser at a flow rate of 200 ml/min for 120 min using a peristaltic pump test. P-values <0.05 are considered to be statistically significant. (Model 7401-PI-EI, DrakeWillock Portland, OR) and dia- Heparinized blood in a waterbath maintained at 37°C was recirculated through the blood compartment of a dialyser using a pump at a flow rate of 200 ml/min. Dialysate was recirculated in the closed dialysate compartment using a pump at a flow rate of 60 ml/min.
CuprophanA membrane dialysers. As expected, plasma

Results
C3a levels increased (P<0.01) rapidly during blood recirculation through CuprophanA membrane diaGeneration and compartmentalization of C3a lysers. The level reached a plateau phase at 60 min Dialysis tubings alone. Plasma C3a levels increased ( Figure 3A ). C3a was detectable in the dialysate com-(P<0.01) gradually during recirculation through dia-partment of CuprophanA dialysers at 120 min, but the lysis tubings alone. An apparent plateau phase was concentration was very low (0.16±0.07 mg/ml ) and reached at 60 min when the mean C3a level was the mass in the dialysate compartment accounted for 1.63 mg/ml (not shown).
only 0.5±0.2% of the total mass in these dialysers ( Table 2) . Adsorption of C3a onto these membranes Polysulfone membrane dialysers. Plasma C3a levels was not quantified. increased (P<0.01) gradually during recirculation through either high flux (Figure 2A ) or low flux AN69A membrane dialysers. Plasma C3a levels were ( Figure 2B ) polysulfone dialysers, reaching an appar-low in the AN69A dialysers and remained stable ent plateau at 60-90 min. At the end of the 120 min throughout the recirculation ( Figure 2C ). At 120 min, experiment, plasma C3a levels for high flux polysulfone plasma C3a level was 0.58±0.06 mg/ml, which equalled (2.31±0.81 mg/ml ) were comparable with those for 37, 25, 19 and 1% of the corresponding plasma levels low flux polysulfone (3.02±0.98 mg/ml ), and were for tubings alone, high flux polysulfone, low flux higher than those for tubings alone (mean 1.56 mg/ml ). polysulfone and CuprophanA dialysers, respectively The C3a concentration in the dialysate compartment ( Table 2 ). C3a was undetectable in the dialysate comof high flux polysulfone dialysers at 120 min was partment of AN69A membrane dialysers. 0.65±0.31 mg/ml, which was substantially higher than that found in the dialysate compartment of low flux polysulfone dialysers at the same time point
Generation and compartmentalization of C5a (0.01±0.01 mg/ml ) ( Table 2 ). The total mass of C3a in the dialyser was calculated as (concentration× CuprophanA membrane dialysers. Plasma C5a levels volume of plasma)+(concentration×volume of increased (P<0.0001) continuously during recirculadialysate); plasma volume was calculated assuming a tion through CuprophanA membrane dialysers and haematocrit value of 45% in the blood sample. The reached 49±9 ng/ml at 120 min ( Figure 3B ). This total C3a mass in high flux polysulfone dialysers pattern was different from that of plasma C3a for the (412±152 mg) was greater than that in low flux polys-same type of dialyser ( Figure 3A) . No C5a was ulfone dialysers (304±99 mg) in five out of six experi-detected in the dialysate compartment at any time. ments, but the difference was not statistically significant. The C3a mass in the dialysate compartment Polysulfone and AN69A membrane dialysers and tubings alone. There was no increase in plasma C5a levels accounted for 37.5±7.0% of the total mass in high flux polysulfone dialysers, but only 0.3±0.3% of the during recirculation through tubings alone, high flux polysulfone, low flux polysulfone or AN69A membrane total mass in low flux polysulfone dialysers. It should be noted that, in these experiments, the C3a which dialysers (data not shown). C5a was undetectable in the dialysate compartment of all these dialysers at any might have been adsorbed onto the dialysis membrane was not quantified. time points. (n=2) for tubings alone. Note that the anaphylatoxin levels associated with each dialyser resulted from the effect of the combination of the dialyser and tubings. ND=not detectable, i.e. below the lower detection limit for the C3a assay (0.04 mg/ml ) and C5a assay (0.01 mg/ml ) respectively. NA=not applicable because there was no dialyser and dialysate.
Anaphylatoxin C3a has been used commonly as a Discussion marker of complement activation during haemodialysis. While both anaphylatoxins are spasmogenic, the Some recent studies have suggested that the type of leukocyte-directed activities of C5a are greater than dialysis membrane employed influences patient survival those of C3a [16 ] . However, the relatively low plasma in both acute [14, 15] and chronic [1] renal failure. The level of C5a, partly as a result of its binding to specific mechanism by which dialysis membrane exerts its effect receptors on leukocyte surfaces [17] , has often been is unclear, but the various degrees to which different cited as a rationale for using C3a instead of C5a as a membranes activate complement, neutrophils and monocytes have been suggested to be a factor. marker of complement activation. Other activation products of C3, such as C3b and iC3b (both with in these dialysers. It should be noted that, in these experiments, the volume of the recirculating dialysate M r~1 80 kDa), can also bind to cytoplasmic membrane receptors (e.g. CR1 and CR3, respectively) and modu-was small (280 ml or only 2.5 times the plasma volume); in addition, there was no net ultrafiltration. late leukocyte function [18] . Under favourable conditions, activation of C3 and C5 is followed by activation During clinical haemodialysis, where dialysate usually flows at 500-1000 ml/min in a single pass fashion, the of the terminal components of complement and formation of the membrane attack complex, C5b-9 (M r concentration gradient between the plasma and dialysate, hence the diffusive loss of solutes, may be greater1500 kDa); this complex has also been shown to be functionally active against leukocytes [5] .
than those in the present study. In addition, net ultrafiltration of plasma water contributes to solute The activation products, C3b, iC3b and C5b-9, are seldom measured for the study of dialysis membrane loss by convection. Therefore, the loss of C3a from plasma during clinical dialysis is expected to be greater biocompatibility, partly because their assays are not widely available, and partly because their plasma levels than that observed in the present experiments.
Adsorption of C3a onto the dialysis membranes was do not increase as drastically as C3a does. In essence, C3a is used commonly as an index of complement not examined in the present study. It is unlikely, however, that the adsorptive capacity of low flux activation during haemodialysis, not necessarily because of its biological activity, but because of the polysulfone membranes is higher than that of high flux polysulfone membranes with the same nominal luminal magnitude of the intradialytic increase in its plasma concentration and the convenience of its assay. If C3a surface area. It thus appears that high flux polysulfone membranes activate complement at least to the same is lost from the blood compartment during haemodialysis, but the other biologically active complement extent, or perhaps even to a greater extent, than low flux polysulfone membranes. activation products are retained, plasma C3a would not provide an accurate indicator of complement In accordance with its known property as a potent activator of complement, there was a large increase in activation. Therefore, a more complete profile of complement activation by dialysis membranes should plasma C3a levels associated with CuprophanA dialysers during blood recirculation. Plasma C3a levels include the measurements of C3a, C3b, iC3b, C5a and C5b-9.
reached a plateau of 45-55 mg/ml after 60 min, in contrast to a continuous increase in plasma C5a levels We have shown previously that the AN69A membrane has a large capacity to adsorb C3a, C5a and reaching~50 ng/ml at the end of the 120 min experiment. This discrepancy can be explained readily by the cytochrome c [11] , thus prohibiting the transport of these molecules into the dialysate compartment despite relative efficiency of C3 activation, such that all the plasma C3 (~1 mg/ml ) had already been converted the high porosity of this membrane. The absence of anaphylatoxins in the dialysate compartment of the into C3a (M r =5% of that of C3) at 60 min. In contrast, the formation of C5 convertase was relative inefficient, AN69A membrane dialysers was confirmed in the present study ( Figure 2C ) . such that only a small fraction (<2%) of the total plasma C5 pool had been activated even at 120 min. The other mechanism by which anaphylatoxins can be lost from the blood compartment is transport into The in vitro time course of plasma C3a changes described herein also differs from that observed during the dialysate compartment. This was demonstrated in the present study for high flux polysulfone ( F60) clinical dialysis using the same type of membrane.
During clinical haemodialysis, plasma C3a levels dialysers (Figure 2A ). The C3a in the dialysate compartment accounted for almost 40% of the total mass achieve peak values at 10-20 min and decline there-
